title: Ileitis secondary to oral capecitabine treatment?
abstract: The efficacy of capecitabine as adjuvant therapy in colon cancer is well demonstrated and its lower toxicity rates when compared with 5-FU make it an increasingly more favourable option for patients. This case highlights the awareness of a potentially severe side effect related to the use of capecitabine, yet through the early identification of symptoms patients can be managed conservatively.
authors.affiliation: Department of Colorectal Surgery, Royal Gwent Hospital, Newport NP20 2UB, UK.
authors.forename: Rami
authors.initials: R
authors.lastname: Radwan
authors.forename: Wanangwa C
authors.initials: WC
authors.lastname: Namelo
authors.forename: Mark
authors.initials: M
authors.lastname: Robinson
authors.forename: Alison E
authors.initials: AE
authors.lastname: Brewster
authors.forename: Gethin L
authors.initials: GL
authors.lastname: Williams